Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

INTRODUCTION: Clinicopathological analyses revealed that reduction in HbA1c and use of insulin independently contribute to reduction in liver fibrosis scores during the course of nonalcoholic fatty liver disease (NAFLD) development. We will test our hypothesis that lowering glucose and increasing in...

Descripción completa

Detalles Bibliográficos
Autores principales: Takeshita, Yumie, Kanamori, Takehiro, Tanaka, Takeo, Kaikoi, Yuka, Kita, Yuki, Takata, Noboru, Iida, Noriho, Arai, Kuniaki, Yamashita, Tatsuya, Harada, Kenichi, Gabata, Toshifumi, Nakamura, Hiroyuki, Kaneko, Shuichi, Takamura, Toshinari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995806/
https://www.ncbi.nlm.nih.gov/pubmed/31956961
http://dx.doi.org/10.1007/s13300-020-00762-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995806/
https://www.ncbi.nlm.nih.gov/pubmed/31956961
http://dx.doi.org/10.1007/s13300-020-00762-9

Ejemplares similares